Implementing Leadership Change
Gene One is a privately owned biotechnology company seeking an initial public offering (IPO). Before transitioning into an IPO company, the Chief Executive Officer, Don Ruiz should consider various options in deciding Gene One’s future. Team A has provided two strategies to help Ruiz in making the correct decision for his company. Strategy one suggests Gene One to continue to work as it is currently, research, and develops more products that Gene One would benefit from in the future. The second strategy focuses on the transition of Gene One becoming an IPO company.
Implementation of Remaining with the Current Strategy
Gene One has grown tremendously with a groundbreaking gene technology in the last eight years. The key players in Gene One need to influence the organization to remain on their successful growth by keeping the business the way it is. Greg Thoman, Chief Human Resources Officer, has “staffed Gene One with talented researchers and innovative product developers” (University of Phoenix, n.d.). Teri Robertson, Chief Technology Officer, has a world-renowned reputation and the led the genetic breakthrough discovery that made Gene One successful (University of Phoenix, n.d.). Teri Robertson can help lead the current researchers and developers continue on their successful developments. The Gene One leaders need to “communicate their values when they articulate a vision for the organization, make statements about the values and ideals that are important, and formulate long-term objectives and strategies for attaining them” (Yukl, 2010, p. 307). Also, Gene One leaders can present “formal budgets, planning sessions, reports, performance review procedures and management development programs can be used to emphasize some values and beliefs about proper behavior” (Yukl, 2010, p. 307). By using the various presentations, this will help leadership emphasize their goals to keep the current vision of the...